
Sign up to save your podcasts
Or


Based on Podcast App listening data
As the nights draw in and the spluttering sounds of coughs and colds seem to be all around us, presenter James Gallagher is getting ahead this year and stocking up his medicine cabinet. He gets some help from Inside Health’s resident GP Margaret McCartney and virologist Lindsay Broadbent from the University of Surrey to take look at a few of the nation’s best-loved remedies and find out what they will actually do to help him when he, inevitably, gets ill.
Presenter: James Gallagher
Speakers:
Producer: Tom Bonnett
Exercise in older age is high on the agenda, but the idea that with age comes bags of time and a desire to ‘get out there’ isn’t true for a lot of us. How do you juggle exercise around caring for partners, grandchildren or staying in work? What if you haven’t exercised for years? What can your body take, and how has it changed with age? James Gallagher hears how octogenarian athlete ‘Irongran’ keeps going, he explores the mental and physical barriers that stop us exercising, and he finds out what he might feel like in 40 years as he pulls on an ageing suit.
Presenter: James Gallagher
Guests:
Producer: Tom Bonnett
The issue of sexual assault hasn’t been far from the headlines in recent weeks - but what kind of help is available for people who have been through it?
James visits Saint Mary’s Sexual Assault Referral Centre in Manchester where he meets the people who offer invaluable medical and emotional support to patients. He also talks to a young woman who describes her experience of using the service, which she credits with saving her life.
And why does Covid-19 seem to be flooring people again? James finds out that the body’s own defences are partly to blame.
Lastly, is it safe to flush dog poo down the toilet? We clear up a family debate…
Presenter: James Gallagher
If you have been affected by child or adult sexual abuse or violence, details of help and support are available at bbc.co.uk/actionline, or you can call for free, at any time to hear recorded information on 0800 077 077.
1 in 7 people live with migraines around the world, and the condition costs the UK economy billions each year. Attacks can be debilitating and all-consuming, but a new treatment recently approved by NICE might even help the most stubborn cases find some relief.
James Gallagher is joined by neurologist Alex Sinclair from the University of Birmingham, GP Richard Wood from Oxford University Hospitals NHS Trust, and physiotherapist Anne-Marie Logan from St George’s University Hospitals to answer your questions on migraine and headache; from understanding why migraines exist in the first place, to if foods like takeaways could be triggers, and what these new treatments mean for the future of migraine management.
Presenter: James Gallagher
How many hours do you spend sitting down per day? Six? Maybe eight? Or 10? Between commuting, working and relaxing, sitting can soon add up to hours and hours.
In this week’s Inside Health we’re going to delve into the science to find out exactly how much sitting is too much; when does it become worrying for our health?
James visits the lab at Leicester University where he meets Professor Charlotte Edwardson to explore what prolonged sitting does to the body and he’ll find out whether there’s anything you can do to offset the effects of sitting a lot.
We’ll hear about the origins of sitting research - and just because we like to explore every angle on a topic, we’ll hear all about why standing too much can also be a worry.
James visits a school in east London where the children are really focusing on how much time they spend sitting. They’re taking part in the Active Movement programme with the aim of bringing lots of action into the school day - and take it home too.
Presenter: James Gallagher
When the Government released the latest statistics on STIs in the summer, one in particular stood out. Syphilis. A sexually transmitted infection which might make you think more 1823 than 2023. But figures in England are currently at their highest since 1948, a rise which is reflected across the UK. James Gallagher speaks to people who have first-hand experience with syphilis to work out why we aren't talking about the disease and it's increase more.
And James gets on his bike with resident GP Margaret McCartney to find out whether tracking her stats via her many exercise monitors is improving her physical and mental health or making it worse. Dr Brendon Stubbs, Clinical-academic physiotherapist at Kings College London and Dr Eoin Whelan, Professor in Business Analytics & Society at the University of Galway help unpick the evidence.
Presenter: James Gallagher
What happens when a new drug hits the UK’s streets? And how are illicit drugs here changing – and why?
James follows the trail of the first case of “zombie drug” xylazine in the UK and hears some powerful personal stories along the way.
The story begins in Solihull, in the West Midlands, where 43-year-old Karl Warburton was found dead in May 2022. He had a mix of xylazine, heroin, fentanyl and cocaine in his body.
James visits a local addiction clinic where Mark describes the fear and compulsion many addicts face. He tells James about his journey to recovery and we meet Simon who’s on a mission to help people like Mark into a new life.
Next, James meets toxicologists at a busy hospital lab in Birmingham where he finds out how xylazine was first detected. Then he travels to London to meet a university academic who first raised the alarm about the drug, and visits a cramped room containing the paper records she keeps detailing every drug death in Britain from the past 25 years.
James goes on a surprising and, at times, emotional journey as he gets a rare insight into the world of illegal drugs and the parts of the NHS that treat addiction.
Presenter: James Gallagher
Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, how much of a difference could these drugs make for people living with the condition?
James Gallagher visits a Memory Café in Doynton to hear about the daily challenges people living with dementia face, and their feelings about the new treatments on the horizon. Lauren Walker, Alzheimer’s disease researcher at Newcastle University, gives an overview of the protein these drugs target in the brain, and Liz Coulthard, Professor of Cognitive Neurology at the University of Bristol, explains how these treatments might impact patient's lives.
Presenter: James Gallagher
Barely a day goes by without more headlines around new weight-loss drugs, from the issue of global shortages, to investigations into suicide risk, and debate over just how long people will need to be on them. But in this episode of Inside Health we’re going to look at something slightly different - and perhaps unexpected.
James Gallagher meets lifelong dieter Cheri who has lost just over three stone on semaglutide but she’s also noticed other effects from her weekly injection; a calmer mind and a complete lack of desire for her much-loved vapes. She wants to know what’s going on – so we seek out some scientists to help us get to the bottom of it. From the evidence gathered so far, are there hints that these drugs could offer potential to treat serious addiction?
And have you ever heard of “bed rotting”?
It doesn’t sound particularly enticing - but James gives it a go in the name of science and we explain all in the programme with the help of two experts.
What health questions do you want us to answer? Email the team at [email protected]
Declared interests:
Presenter: James Gallagher
One year after the peak of UK infections, can we determine what actions brought mpox cases down?
A year ago, mpox – the virus formally known as monkeypox – was spreading in the UK. These infections largely impacted the gay, bisexual and men who have sex with men community, with news cases peaking at 350 per week. One of these individuals was Martin Joseph, who tells James Gallagher how a lack of accessible information and the stigma he observed during his illness inspired him to create a mpox-based podcast so others wouldn’t feel so alone.
Thankfully, 2023 so far has told a different story for mpox. Infections in the UK have remained relatively low, and in May, the World Health Organisation declared the mpox global health emergency over. But what helped bring the UK outbreak under control? James is joined by Jake Dunning, infectious diseases doctor and researcher at the University of Oxford, and Claire Dewsnap, sexual health doctor and president of the British Association of Sexual Health and HIV (BASHH), to discuss potential factors, takeaways and whether we are really ‘done’ with mpox.
How often should we go to the dentist? Listener Mary emailed [email protected] to query the time needed between check-ups. James hears the evidence from Janet Clarkson, professor of dentistry at the University of Dundee, who explains the unlikely origins of our bi-annual appointments!
Presenter: James Gallagher
(Photo: Monkeypox Credit: Uma Shankar sharma | Getty Images)
From the publisher's feed
Series that demystifies health issues, separating fact from fiction and bringing clarity to conflicting health advice.
Ranked by our users in the last 21 days

7,593 Listeners

880 Listeners

1,050 Listeners

42 Listeners

5,526 Listeners

1,804 Listeners

1,802 Listeners

1,037 Listeners

1,952 Listeners

93 Listeners

262 Listeners

351 Listeners

386 Listeners

411 Listeners

241 Listeners

66 Listeners

488 Listeners

564 Listeners

147 Listeners

3,157 Listeners

820 Listeners

1,005 Listeners

183 Listeners

2,031 Listeners

99 Listeners